Found: 128
Select item for more details and to access through your institution.
How affordable are targeted therapies in non-small cell lung cancer?
- Published in:
- 2011
- By:
- Publication type:
- journal article
Economic Considerations in the Use of Novel Targeted Therapies for Lung Cancer: Review of Current Literature.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Implementation of Liquid Biopsy in Non-Small-Cell Lung Cancer: An Ontario Perspective.
- Published in:
- Current Oncology, 2024, v. 31, n. 10, p. 6017, doi. 10.3390/curroncol31100449
- By:
- Publication type:
- Article
Promising targets and current clinical trials in metastatic non-squamous NSCLC.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00329
- By:
- Publication type:
- Article
Economic impact of tissue testing and treatments of metastatic NSCLC in the era of personalized medicine.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00258
- By:
- Publication type:
- Article
Biomarkers that currently effect clinical practice in lung cancer: EGFR, ALK, MET, ROS-1 and KRAS.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00204
- By:
- Publication type:
- Article
Analysis of Adjuvant Chemotherapy in Non-Small Cell Lung Cancer.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 2, p. 37
- By:
- Publication type:
- Article
Pathological Subtyping and Molecular Profiling in Non-small Cell Lung Cancer: A Clinician's Perspective.
- Published in:
- Canadian Journal of Pathology, 2014, p. 158
- By:
- Publication type:
- Article
Emerging therapies for non-small cell lung cancer.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0731-8
- By:
- Publication type:
- Article
Symptom screening with Targeted Early Palliative care (STEP) versus usual care for patients with advanced cancer: a mixed methods study.
- Published in:
- Supportive Care in Cancer, 2023, v. 31, n. 7, p. 1, doi. 10.1007/s00520-023-07870-9
- By:
- Publication type:
- Article
Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 1, p. 50, doi. 10.1093/nop/npab056
- By:
- Publication type:
- Article
Treatment decision for recurrences in non-small cell lung cancer during or after adjuvant osimertinib: an international Delphi consensus report.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1330468
- By:
- Publication type:
- Article
The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221112696
- By:
- Publication type:
- Article
Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients.
- Published in:
- Current Oncology, 2021, v. 28, n. 6, p. 5278, doi. 10.3390/curroncol28060441
- By:
- Publication type:
- Article
Canadian Consensus Recommendations on the Management of MET-Altered NSCLC.
- Published in:
- Current Oncology, 2021, v. 28, n. 6, p. 4552, doi. 10.3390/curroncol28060386
- By:
- Publication type:
- Article
Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer—A Cost-Efficient Strategy in a Public Healthcare System.
- Published in:
- Current Oncology, 2021, v. 28, n. 5, p. 3268, doi. 10.3390/curroncol28050284
- By:
- Publication type:
- Article
Adherence to human epidermal growth factor receptor-2 testing and adjuvant trastuzumab treatment guidelines in Ontario.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 2, p. 379, doi. 10.1177/1078155219850299
- By:
- Publication type:
- Article
Traitement ciblé oral contre le cancer du poumon non à petites cellules.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2024, v. 196, n. 22, p. E770, doi. 10.1503/cmaj.231562-f
- By:
- Publication type:
- Article
Oral targeted therapy for the treatment of non–small cell lung carcinoma.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2024, v. 196, n. 16, p. E558, doi. 10.1503/cmaj.231562
- By:
- Publication type:
- Article
Longitudinal Assessment of Health Utility Scores, Symptoms and Toxicities in Patients with Small Cell Lung Cancer Using Real World Data.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 2, p. e154, doi. 10.1016/j.cllc.2021.09.006
- By:
- Publication type:
- Article
Treatment Patterns and Outcomes of Patients With Advanced Pleural Mesothelioma at an Academic Referral Centre.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. e43, doi. 10.1016/j.cllc.2021.08.003
- By:
- Publication type:
- Article
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non–Small Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. 72, doi. 10.1016/j.cllc.2021.10.001
- By:
- Publication type:
- Article
Systemic Inflammatory Markers of Survival in Epidermal Growth Factor–Mutated Non–Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 5, p. 390, doi. 10.1016/j.cllc.2021.01.002
- By:
- Publication type:
- Article
Subtypes of EGFR- and HER2-Mutant Metastatic NSCLC Influence Response to Immune Checkpoint Inhibitors.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 4, p. 253, doi. 10.1016/j.cllc.2020.12.015
- By:
- Publication type:
- Article
Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair–Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G.
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. 187, doi. 10.1016/j.cllc.2021.01.001
- By:
- Publication type:
- Article
A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753).
- Published in:
- Clinical Lung Cancer, 2021, v. 22, n. 3, p. 170, doi. 10.1016/j.cllc.2020.09.013
- By:
- Publication type:
- Article
Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care System.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Effect of Coexisting KRAS and TP53 Mutations in Patients Treated With Chemotherapy for Non-small-cell Lung Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Rationale and Protocol for a Canadian Multicenter Phase II Randomized Trial Assessing Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-small-cell Lung Cancer (NCT02788461).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Correlation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in Patients With Advanced Non-Small-Cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Radical Treatment of Stage II Non-small-cell Lung Cancer With Nonsurgical Approaches: A Multi-institution Report of Outcomes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Real-World EQ5D Health Utility Scores for Patients With Metastatic Lung Cancer by Molecular Alteration and Response to Therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Evolution of Symptom Burden of Advanced Lung Cancer Over a Decade.
- Published in:
- 2017
- By:
- Publication type:
- journal article
ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Cost-Effectiveness Analysis of Using the JBR.10-Based 15-Gene Expression Signature to Guide Adjuvant Chemotherapy in Early Stage Non-Small-Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non-Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase II Study of Concurrent Pemetrexed, Cisplatin, and Radiation Therapy for Stage IIIA/B Unresectable Non-Small Cell Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non-Small-Cell Lung Cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Correlation of Dosimetric and Clinical Factors With the Development of Esophagitis and Radiation Pneumonitis in Patients With Limited-Stage Small-Cell Lung Carcinoma.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 3, p. 216, doi. 10.1016/j.cllc.2014.11.008
- By:
- Publication type:
- Article
A Phase II Trial of Saracatinib, an Inhibitor of src Kinases, in Previously-Treated Advanced Non--Small-Cell Lung Cancer: The Princess Margaret Hospital Phase II Consortium.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 1, p. 52, doi. 10.1016/j.cllc.2013.08.001
- By:
- Publication type:
- Article
Third-Line Chemotherapy in Small-Cell Lung Cancer: An International Analysis.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 2, p. 110, doi. 10.1016/j.cllc.2013.11.003
- By:
- Publication type:
- Article
A Phase II Trial of Saracatinib, an Inhibitor of src Kinases, in Previously-Treated Advanced Non-Small-Cell Lung Cancer: The Princess Margaret Hospital Phase II Consortium.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Chemoradiotherapy for locoregional recurrence of non-small-cell lung cancer after surgical resection: a retrospective analysis.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Randomized Phase II Trial of Concurrent Versus Sequential Bortezomib Plus Docetaxel in Advanced Non-Small-Cell Lung Cancer: A California Cancer Consortium Trial.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 1, p. 33, doi. 10.3816/CLC.2011.n.004
- By:
- Publication type:
- Article
Classification and Toxicities of Vascular Disrupting Agents.
- Published in:
- Clinical Lung Cancer, 2011, v. 12, n. 1, p. 18, doi. 10.3816/CLC.2011.n.002
- By:
- Publication type:
- Article
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-023-44512-4
- By:
- Publication type:
- Article
The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211056306
- By:
- Publication type:
- Article
The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211056306
- By:
- Publication type:
- Article